本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Arcutis Biotherapeutics Inc.

24.90
+1.395.91%
成交量:182.13萬
成交額:4,530.84萬
市值:31.14億
市盈率:115.59
高:25.62
開:23.63
低:23.63
收:23.51
52周最高:31.77
52周最低:16.57
股本:1.25億
流通股本:1.11億
量比:2.35
換手率:1.64%
股息:- -
股息率:- -
每股收益(TTM):0.2154
每股收益(LYR):-0.1269
淨資產收益率:15.86%
總資產收益率:5.09%
市淨率:14.12
市盈率(LYR):-196.28

資料載入中...

2024/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/13

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/11/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/14

重要事件披露

Form 8-K - Current report
2024/08/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities